Published in Hepatitis Weekly, May 24th, 2010
"Their structures were determined based on extensive spectroscopic analysis and X-ray single crystal crystallography," wrote C.A. Geng and colleagues, Chinese Academy of Science.
The researchers concluded: "Our anti-HBV assay on the Hep G 2.2.15 cell line in vitro showed that compounds 1 and 2 exhibited significant inhibitory activities against the secretion of HBsAg with IC50 of 0.22 and 0.70 mM and HBeAg with IC50 of 0.52 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.